Dr. Jesus G Berdeja, MD
Claim this profileTennessee Oncology
About Jesus G Berdeja, MD
Education:
- Obtained MD from the University of Texas Southwestern Medical School, graduating in 2001.
- Completed Residency in Internal Medicine at Vanderbilt University Medical Center in 2004.
- Finished Fellowship in Hematology/Oncology at Vanderbilt University Medical Center in 2007.
Experience:
- Director of Myeloma Research and Senior Vice President of Clinical Research at Tennessee Oncology.
- Professor of Medicine at Vanderbilt University Medical Center.
Area of expertise
Multiple Myeloma
Jesus G Berdeja, MD has run 16 trials for Multiple Myeloma. Some of their research focus areas include:
Relapse
Jesus G Berdeja, MD has run 6 trials for Relapse.
Affiliated Hospitals
Tennessee Oncology
Sarah Cannon Cancer Center
Clinical Trials Jesus G Berdeja, MD is currently running
Iberdomide vs Lenalidomide
for Multiple Myeloma
This trial is testing two treatments, iberdomide and lenalidomide, to see which one is better at preventing cancer from coming back in patients with newly diagnosed multiple myeloma after a stem cell transplant. These treatments help the immune system fight off cancer cells. Lenalidomide has been used for the treatment of multiple myeloma, showing effectiveness and improving survival outcomes.
Recruiting
2 awards
Phase 3
MMSET Inhibitor
for Multiple Myeloma
This trial tests a new pill that blocks an enzyme to help treat adults with a hard-to-treat type of blood cancer. The goal is to see if it is safe and effective.
Recruiting
1 award
Phase 1
13 criteria
More about Jesus G Berdeja, MD
Clinical Trial Related
4 years of experience running clinical trials · Led 19 trials as a Principal Investigator · 5 Active Clinical Trials
Treatments Jesus G Berdeja, MD has experience with
- Dexamethasone
- Daratumumab
- Pomalidomide
- Bortezomib
- Carfilzomib
- Iberdomide
Breakdown of trials Jesus G Berdeja, MD has run
Multiple Myeloma
Plasma Cell Neoplasm
Cancer
Other Doctors you might be interested in
Frequently asked questions
Do I need insurance to participate in a trial?
Almost all clinical trials will cover the cost of the ‘trial drug’ — so no insurance is required for this. For trials where this trial drug is given alongside an already-approved medication, there may be a cost (which your insurance would normally cover).
What does Jesus G Berdeja, MD specialize in?
Jesus G Berdeja, MD focuses on Multiple Myeloma and Relapse. In particular, much of their work with Multiple Myeloma has involved t(4;14) positive patients, or patients who are GOF mutation in MMSET positive.
Is Jesus G Berdeja, MD currently recruiting for clinical trials?
Yes, Jesus G Berdeja, MD is currently recruiting for 5 clinical trials in Nashville Tennessee. If you're interested in participating, you should apply.
Are there any treatments that Jesus G Berdeja, MD has studied deeply?
Yes, Jesus G Berdeja, MD has studied treatments such as Dexamethasone, Daratumumab, Pomalidomide.
What is the best way to schedule an appointment with Jesus G Berdeja, MD?
Apply for one of the trials that Jesus G Berdeja, MD is conducting.
What is the office address of Jesus G Berdeja, MD?
The office of Jesus G Berdeja, MD is located at: Tennessee Oncology, Nashville, Tennessee 37203-1625 United States. This is the address for their practice at the Tennessee Oncology.
Is there any support for travel costs?
The coverage of travel expenses can vary greatly between different clinical trials. Please see more financial detail in the trials you’re interested to apply.
Unbiased Results
We believe in providing patients with all the options.
Your Data Stays Your Data
We only share your information with the clinical trials you're trying to access.
Verified Trials Only
All of our trials are run by licensed doctors, researchers, and healthcare companies.